MedTrace Logo

The Vitamin B Status in Type 2 Diabetes (VITA) Study

NCT03447275 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 174

Last updated 2018-05-14

No results posted yet for this study

Summary

The objective of this study was to evaluate vitamin B deficiency (particularly vitamin B6 deficiency) in diabetic patients in Germany in relation to the presence or absence of proteinuria, and global vascular risk.

Conditions

  • Diabetes Mellitus, Type 2
  • Vitamin B 12 Deficiency
  • Vitamin B 6 Deficiency

Interventions

OTHER

Type 2 diabetes

Test if patients with diabetes have different blood concentrations of vitamin biomarkers compared with control subjects and if vitamin levels in the patients will differ according to renal damage.

Sponsors & Collaborators

  • Merck KGaA, Darmstadt, Germany

    collaborator INDUSTRY

  • Syneed Medidata GmbH

    collaborator INDUSTRY

  • Rima Obeid

    lead OTHER

Principal Investigators

  • Wilfred A Nix, PhD · Department of Neurology, Medical University of Mainz, 55131 Mainz, Germany

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2011-09-30
Completion
2011-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03447275 on ClinicalTrials.gov